Clinical Trial Update: Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds [Phase 2]

View source ↗

Summary

Phase 2 trial of the Meningococcal ACYWX Conjugate Vaccine in 12- to 16-month-old children has completed; results were posted on 2021-09-05.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Meningococcal ACYWX Conjugate Vaccine

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Meningitis, Meningococcal | Phase 2 | Status: COMPLETED | Results posted: 2021-09-05